RHTLaw Asia has advised RegASK, a global regtech SaaS platform that enables businesses to leverage AI to scale their regulatory and compliance capabilities, on its $10m Series A funding round. This round was led by life sciences venture firm Monograph Capital.
The funding will be used to further invest in the platform and bring RegASK to all companies seeking to strengthen their regulatory capabilities around the globe. The funding follows on the heels of the expansion of RegASK platform to serve new industries including biopharma and decentralised clinical trials regulation, in addition to the existing deployment in consumer health, medtech, and food industries.
The deal was led by Partner (Foreign Lawyer) and Co-Head of Corporate & Capital Markets Practice, Erwan Barre. Based in the Singapore office, Erwan advises clients across Asia Pacific on cross-border corporate transactions principally in the technology and healthcare industries. Erwan is widely recognised as a leading lawyer in the Who’s Who Legal and Chambers Asia-Pacific legal publications.
RHTLaw Asia is a member of ONERHT, an integrated network of multidisciplinary professional and specialist services which empowers stakeholders to achieve purposeful growth.
© 2024 RHTLaw Asia LLP. All Rights Reserved.
